Cognitive Behavioral Therapy for Painful Diabetic Neuropathy
NCT ID: NCT00830011
Last Updated: 2011-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2004-09-30
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Therapy for Diabetic Neuropathic Pain
NCT00829387
Graded Exposure in Patients With Painful Diabetic Neuropathy
NCT03066570
The Development of Contextual Cognitive Behavioural Approach to PDN
NCT03700528
Thermal Biofeedback for the Treatment of Diabetic Neuropathy
NCT00858351
Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy
NCT00955201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methodology: Study participants will be evaluated pre-treatment (baseline), 12 weeks post-baseline (post-treatment) and at 24 and 36 weeks post-baseline (follow-up). Baseline assessment will include a neurological examination with a nerve conduction study to confirm the diagnosis of diabetic neuropathy. The primary outcome measure will be pain intensity. Secondary outcome measures will be pain quality, pain-related disability, physical and emotional functioning. Measures of treatment feasibility will also be examined. Participants receiving CBT will attend 10 weekly, group treatment sessions of 90 minutes. A target sample size of approximately 120 participants will be recruited.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care
Medical care including medication for neuropathic pain
standard medical care
any care recommended by physician for treatment of diabetic neuropathy including medication.
CBT
cognitive behavioral therapy
Ten sessions of manualized CBT delivered by a PhD level psychologist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive behavioral therapy
Ten sessions of manualized CBT delivered by a PhD level psychologist
standard medical care
any care recommended by physician for treatment of diabetic neuropathy including medication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* daily lower extremity pain or discomfort (burning, tingling or other parasthesias) for at least 3 months
* documented trial of at least one medication for neuropathic pain
* pain of at least 4 on a 0-10 numeric rating scale
Exclusion Criteria
* dementia (MMSE score of 23 or lower)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Donaghue Medical Research Foundation
OTHER
VA Connecticut Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
VA Connecticut Healthcare System
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Kerns, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Connecticut Healthcare System
References
Explore related publications, articles, or registry entries linked to this study.
Higgins DM, Heapy AA, Buta E, LaChappelle KM, Serowik KL, Czlapinski R, Kerns RD. A randomized controlled trial of cognitive behavioral therapy compared with diabetes education for diabetic peripheral neuropathic pain. J Health Psychol. 2022 Mar;27(3):649-662. doi: 10.1177/1359105320962262. Epub 2020 Oct 19.
Related Links
Access external resources that provide additional context or updates about the study.
American Diabetes Association
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DF03-35
Identifier Type: -
Identifier Source: secondary_id
RK0029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.